Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome
Open Access
- 16 October 2011
- journal article
- review article
- Published by Hindawi Limited in Journal of Nutrition and Metabolism
- Vol. 2012, 1-7
Abstract
Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including visceral obesity, glucose intolerance or type 2 diabetes, elevated triglycerides, reduced HDL cholesterol, and hypertension. MetS is rapidly increasing in prevalence worldwide as a consequence of the “epidemic” obesity, with a considerable impact on the global incidence of cardiovascular disease and type 2 diabetes. At present, there is a growing interest on the role of visceral fat accumulation in the occurrence of MetS. In this review, the effects of adipocytokines and other proinflammatory factors produced by fat accumulation on the occurrence of the MetS have been also emphasized. Accordingly, the “hypoadiponectinemia” has been proposed as the most interesting new hypothesis to explain the pathophysiology of MetS.Keywords
This publication has 47 references indexed in Scilit:
- Common variation in the adiponectin gene has an effect on systolic blood pressureJournal of Human Hypertension, 2011
- Emerging role of adipokines as mediators in atherosclerosisWorld Journal of Cardiology, 2010
- Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged MenJACC, 2006
- The metabolic syndrome and adipocytokinesFEBS Letters, 2006
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Hypoadiponectinemia Is an Independent Risk Factor for HypertensionHypertension, 2004
- Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential HypertensionHypertension, 2003
- Secretion of Adiponectin and Regulation of apM1 Gene Expression in Human Visceral Adipose TissueBiochemical and Biophysical Research Communications, 2001
- Adiponectin gene expression is inhibited by β‐adrenergic stimulation via protein kinase A in 3T3‐L1 adipocytesFEBS Letters, 2001
- Insulin Resistance, Hyperinsulinemia, and Blood PressureHypertension, 1997